Inventor
JEFFREY BOYINGTON
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
C12NMicroorganisms or enzymes24%
C12YEnzymes12%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
B82YSpecific uses or applications of nanostructures4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
12,053,519HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use202412,053,520Glycan-masked engineered outer domains of HIV-1 gp120 and their use202411,981,707Prefusion RSV F proteins and their use202411,939,356Self-assembling insect ferritin nanoparticles202411,235,056Glycan-masked engineered outer domains of HIV-1 gp120 and their use202211,136,356Recombinant HIV-1 envelope proteins and their use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to US HEALTH (6)· patent assignee history
2021–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| US HEALTH | 6 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2021–2024 |